Currently out of the existing stock ratings of Martin Auster, 87 are a BUY (69.6%), 7 are a SELL (5.6%), 31 are a HOLD (24.8%).

Martin Auster

Work Performance Price Targets & Ratings Chart

Analyst Martin Auster works with a stock forecast success ratio of 55.72% fulfilled within 171.31 days on average. Previously, Martin Auster worked at CREDIT SUISSE.

Martin Auster’s has documented 262 price targets and ratings displayed on 26 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 18-Sep-2023.

Wall Street Analyst Martin Auster

Analyst best performing recommendations are on SLDB (SOLID BIOSCIENCES LLC).
The best stock recommendation documented was for SLDB (SOLID BIOSCIENCES LLC) at 5/14/2019. The price target of $90 was fulfilled within 1 day with a profit of $4.8 (5.06%) receiving and performance score of 50.63.

Average potential price target upside

ALXN Alexion Pharmaceuticals ALXO Alx Oncology Holdings  ANAB AnaptysBio ARNA Arena Pharmaceuticals BMRN Biomarin Pharmaceutical ESPR Esperion Therapeutics ETTX Entasis Therapeutics Holdings FLXN Flexion Therapeutics INSM Insmed MYOK MyoKardia PTCT PTC Therapeutics RARE Ultragenyx SLDB Solid Biosciences LLC SPRB Spruce Biosciences  SRPT Sarepta Therapeutics STOK Stoke Therapeutics UTHR United Therapeutics XLRN Acceleron Pharma OBSV ObsEva SA ONCE Spark Therapeutics GLTO Galecto  RXDX Prometheus Biosciences INBX Inhibrx  CVAC CureVac NV KURA Kura Oncology NTLA Intellia Therapeutics

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

205

$22.5 (12.33%)

2 years 11 months 14 days ago

3/5 (60%)

$35.09 (20.65%)

938

Hold

173

$-9.5 (-5.21%)

156

2 years 11 months 16 days ago

14/24 (58.33%)

$2.73 (1.60%)

682

Hold

190

$7.5 (4.11%)

194

3 years 2 months 15 days ago

9/11 (81.82%)

$34.41 (22.12%)

350

Hold

166

$-16.5 (-9.04%)

175

3 years 2 months 15 days ago

23/23 (100%)

$10.41 (6.69%)

828

Buy

155

3 years 3 months 12 days ago

7/7 (100%)

$36.79 (31.12%)

395

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Martin Auster?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?